Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
898
-
Total 13F shares, excl. options
-
126M
-
Shares change
-
-3.01M
-
Total reported value, excl. options
-
$24.5B
-
Value change
-
-$715M
-
Put/Call ratio
-
1.34
-
Number of buys
-
355
-
Number of sells
-
-481
-
Price
-
$193.84
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q3 2024
1,071 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q3 2024.
BIOGEN INC. - Common Stock (BIIB) has 898 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 126M shares
of 147M outstanding shares and own 85.85% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (16.7M shares), PRIMECAP MANAGEMENT CO/CA/ (16.3M shares), BlackRock, Inc. (15.3M shares), STATE STREET CORP (7.34M shares), JPMORGAN CHASE & CO (5.26M shares), WELLINGTON MANAGEMENT GROUP LLP (5.13M shares), T. Rowe Price Investment Management, Inc. (4.26M shares), GEODE CAPITAL MANAGEMENT, LLC (3.61M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.91M shares), and MORGAN STANLEY (1.89M shares).
This table shows the top 898 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.